160 related articles for article (PubMed ID: 19135937)
1. A non-leaky Artemis-deficient mouse that accurately models the human severe combined immune deficiency phenotype, including resistance to hematopoietic stem cell transplantation.
Xiao Z; Dunn E; Singh K; Khan IS; Yannone SM; Cowan MJ
Biol Blood Marrow Transplant; 2009 Jan; 15(1):1-11. PubMed ID: 19135937
[TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
[TBL] [Abstract][Full Text] [Related]
3. T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells.
Xiao TZ; Singh K; Dunn E; Ramachandran R; Cowan MJ
Biol Blood Marrow Transplant; 2012 Feb; 18(2):200-9. PubMed ID: 22015994
[TBL] [Abstract][Full Text] [Related]
4. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
[TBL] [Abstract][Full Text] [Related]
5. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
[TBL] [Abstract][Full Text] [Related]
6. Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency.
Multhaup MM; Podetz-Pedersen KM; Karlen AD; Olson ER; Gunther R; Somia NV; Blazar BR; Cowan MJ; McIvor RS
Hum Gene Ther; 2015 Apr; 26(4):232-43. PubMed ID: 25738323
[TBL] [Abstract][Full Text] [Related]
7. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Health Outcome and Quality of Life Post-HSCT for IL7Rα-, Artemis-, RAG1- and RAG2-Deficient Severe Combined Immunodeficiency: a Single Center Report.
Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
J Clin Immunol; 2018 Aug; 38(6):727-732. PubMed ID: 30105620
[TBL] [Abstract][Full Text] [Related]
9. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice.
Rooney S; Sekiguchi J; Zhu C; Cheng HL; Manis J; Whitlow S; DeVido J; Foy D; Chaudhuri J; Lombard D; Alt FW
Mol Cell; 2002 Dec; 10(6):1379-90. PubMed ID: 12504013
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of 22q11.2 deletion syndrome and artemis deficiency in two children with T-B-NK+ immunodeficiency.
Heimall J; Keller M; Saltzman R; Bunin N; McDonald-McGinn D; Zakai E; de Villartay JP; Moshous D; Ariue B; McCarthy EA; Devlin BH; Parikh S; Buckley RH; Markert ML
J Clin Immunol; 2012 Oct; 32(5):1141-4. PubMed ID: 22864628
[TBL] [Abstract][Full Text] [Related]
12. Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.
Mostoslavsky G; Fabian AJ; Rooney S; Alt FW; Mulligan RC
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16406-11. PubMed ID: 17062750
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo.
Multhaup MM; Gurram S; Podetz-Pedersen KM; Karlen AD; Swanson DL; Somia NV; Hackett PB; Cowan MJ; McIvor RS
DNA Cell Biol; 2011 Oct; 30(10):751-61. PubMed ID: 21663454
[TBL] [Abstract][Full Text] [Related]
14. Artemis deficiency confers a DNA double-strand break repair defect and Artemis phosphorylation status is altered by DNA damage and cell cycle progression.
Wang J; Pluth JM; Cooper PK; Cowan MJ; Chen DJ; Yannone SM
DNA Repair (Amst); 2005 May; 4(5):556-70. PubMed ID: 15811628
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan.
Inoue K; Miyamoto S; Tomomasa D; Adachi E; Azumi S; Horikoshi Y; Ishihara T; Osone S; Kawahara Y; Kudo K; Kato Z; Ohnishi H; Kashimada K; Imai K; Ohara O; van Zelm MC; Cowan MJ; Morio T; Kanegane H
J Clin Immunol; 2023 Apr; 43(3):585-594. PubMed ID: 36385359
[TBL] [Abstract][Full Text] [Related]
16. Novel spontaneous deletion of artemis exons 10 and 11 in mice leads to T- and B-cell deficiency.
Barthels C; Puchałka J; Racek T; Klein C; Brocker T
PLoS One; 2013; 8(9):e74838. PubMed ID: 24069355
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T-lymphocyte-associated protein 4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky severe combined immunodeficiency.
Humblet-Baron S; Schönefeldt S; Garcia-Perez JE; Baron F; Pasciuto E; Liston A
J Allergy Clin Immunol; 2017 Nov; 140(5):1394-1403.e8. PubMed ID: 28185879
[TBL] [Abstract][Full Text] [Related]
18. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells.
Rooney S; Alt FW; Lombard D; Whitlow S; Eckersdorff M; Fleming J; Fugmann S; Ferguson DO; Schatz DG; Sekiguchi J
J Exp Med; 2003 Mar; 197(5):553-65. PubMed ID: 12615897
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow.
Noordzij JG; Verkaik NS; van der Burg M; van Veelen LR; de Bruin-Versteeg S; Wiegant W; Vossen JM; Weemaes CM; de Groot R; Zdzienicka MZ; van Gent DC; van Dongen JJ
Blood; 2003 Feb; 101(4):1446-52. PubMed ID: 12406895
[TBL] [Abstract][Full Text] [Related]
20. Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells.
Wiekmeijer AS; Pike-Overzet K; IJspeert H; Brugman MH; Wolvers-Tettero IL; Lankester AC; Bredius RG; van Dongen JJ; Fibbe WE; Langerak AW; van der Burg M; Staal FJ
J Allergy Clin Immunol; 2016 Feb; 137(2):517-526.e3. PubMed ID: 26441229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
